CAS 60772-67-0 - Manufacturers, Factory, Suppliers from China

CAS 60772-67-0, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.12.12 08:45:07
2022.08.23 04:40:32
2022.08.03 15:36:35
2022.04.21 01:46:08
2022.03.09 02:17:14
2021.11.03 18:23:29

CAS 60772-67-0 - Manufacturers, Factory, Suppliers from China

Related Products

3-Isopropoxybenzoic Acid CAS 60772-67-0

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

5-Chloro-2-Pentanone CAS 5891-21-4 Purity >98.0% (GC) Factory

2-Hydroxypyridine CAS 142-08-5 Assay >99.0% (HPLC) Factory High Quality

N'-Formyl-L-Kynurenine CAS 3978-11-8 Purity >98.0% (HPLC)

3-Ethynylthiophene CAS 67237-53-0 Purity >98.0% (GC) Factory Hot Sale

5-Methoxyindole-2-Carboxylic Acid Ethyl Ester CAS 4792-58-9 Purity >98.5% (HPLC) Factory High Quality

4-Nitro-L-Phenylalanine Monohydrate CAS 207591-86-4 H-Phe(4-NO2)-OH·H2O Purity >99.0% (HPLC) Factory

3-Aminopiperidine-2,6-Dione Hydrochloride CAS 24666-56-6; 2686-86-4 Purity >99.0% Lenalidomide Intermediate Factory

2,6-Dimethylpyrazine CAS 108-50-9 Purity >98.0% (GC)

2-Methoxypyrazine CAS 3149-28-8 Purity >99.5% (HPLC) Factory

7-Methoxybenzofuran-2-Carboxylic Acid CAS 4790-79-8 Purity ≥98.0% (HPLC)

4-Hydroxy-2,6-dimethoxybenzaldehyde CAS 22080-96-2 High Quality

Fmoc-2-Nal-OH CAS 112883-43-9 Fmoc-3-(2-Naphthyl)-L-Alanine Purity >99.0% (HPLC)

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Xi presents award to top scientists

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Method Of Analyzing Palladium Content In Palladium Catalysts

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.12.12 08:45:07

2022.08.23 04:40:32

2022.08.03 15:36:35

2022.04.21 01:46:08

2022.03.09 02:17:14

2021.11.03 18:23:29

related search